Showing results (241-250 of 362) with videos related to
Sort By:
Pageof 37
Journal of Clinical Pathology|August 1, 1994
Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee)A D Spigelman, I C Talbot, C Penna, et al.American Journal of Physiology. Renal Physiology|September 29, 2005
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failureLisa C Costello-Boerrigter, William B Smith, Guido Boerrigter, et al.Surgical Neurology International|November 9, 2023
Resection of a lumbar intradural tumorJoseph Yunga Tigre, Andrew J Kloehn, Ava Scemama, et al.Cell Reports|December 28, 2017
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT GenesJosh Lewis Stern, Richard D Paucek, Franklin W Huang, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 24, 2009
B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivityGuido Boerrigter, Lisa C Costello-Boerrigter, Gail J Harty, et al.Molecular Cancer Research : MCR|May 5, 2021
Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the BreastJoseph L Sottnik, Evelyn K Bordeaux, Sanjana Mehrotra, et al.British Journal of Haematology|November 1, 1992
Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 casesJ Mercieca, E Matutes, E Moskovic, et al.Blood|April 1, 1981
Hairy cell leukemia and myelomatosis: chance association or clinical manifestations of the same B-cell disease spectrumD Catovesky, C Costello, D Loukopoulos, et al.Nature Reviews. Genetics|July 16, 2016
Crowdsourcing biomedical research: leveraging communities as innovation enginesJulio Saez-Rodriguez, James C Costello, Stephen H Friend, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer modelJiang Liu, Penny C Costello, Nhu-An Pham, et al.Pageof 37